With second quarter results in hand, Novadaq (NVDQ) continues to look like a rare med-tech story with both very strong growth and large addressable markets trading at something close to a reasonable valuation. "Reasonable" is a subjective assessment, of course, it will take many years of exceptional growth for Novadaq to earn its valuation, but I believe the company's strong portfolio of surgical imaging technologies can drive that growth.
Please read the full article at Seeking Alpha:
Novadaq On Track To Bring Excellent Growth To Light
Seeking Alpha: Novadaq On Track To Bring Excellent Growth To Light
0 comments:
Post a Comment